These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11159934)

  • 1. Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity.
    Sunada Y; Ohi H; Hase A; Ohi H; Hosono T; Arata S; Higuchi S; Matsumura K; Shimizu T
    Hum Mol Genet; 2001 Feb; 10(3):173-8. PubMed ID: 11159934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity.
    Ohsawa Y; Toko H; Katsura M; Morimoto K; Yamada H; Ichikawa Y; Murakami T; Ohkuma S; Komuro I; Sunada Y
    Hum Mol Genet; 2004 Jan; 13(2):151-7. PubMed ID: 14645200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
    Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
    Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CAV3 microdeletion differentially affects skeletal muscle and myocardium.
    Cagliani R; Bresolin N; Prelle A; Gallanti A; Fortunato F; Sironi M; Ciscato P; Fagiolari G; Bonato S; Galbiati S; Corti S; Lamperti C; Moggio M; Comi GP
    Neurology; 2003 Dec; 61(11):1513-9. PubMed ID: 14663034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-3 deficiency causes muscle degeneration in mice.
    Hagiwara Y; Sasaoka T; Araishi K; Imamura M; Yorifuji H; Nonaka I; Ozawa E; Kikuchi T
    Hum Mol Genet; 2000 Dec; 9(20):3047-54. PubMed ID: 11115849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease.
    Kubisch C; Schoser BG; von Düring M; Betz RC; Goebel HH; Zahn S; Ehrbrecht A; Aasly J; Schroers A; Popovic N; Lochmüller H; Schröder JM; Brüning T; Malin JP; Fricke B; Meinck HM; Torbergsen T; Engels H; Voss B; Vorgerd M
    Ann Neurol; 2003 Apr; 53(4):512-20. PubMed ID: 12666119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.
    Woodman SE; Sotgia F; Galbiati F; Minetti C; Lisanti MP
    Neurology; 2004 Feb; 62(4):538-43. PubMed ID: 14981167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.
    Minetti C; Sotgia F; Bruno C; Scartezzini P; Broda P; Bado M; Masetti E; Mazzocco M; Egeo A; Donati MA; Volonte D; Galbiati F; Cordone G; Bricarelli FD; Lisanti MP; Zara F
    Nat Genet; 1998 Apr; 18(4):365-8. PubMed ID: 9537420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
    Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
    Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation.
    Vorgerd M; Ricker K; Ziemssen F; Kress W; Goebel HH; Nix WA; Kubisch C; Schoser BG; Mortier W
    Neurology; 2001 Dec; 57(12):2273-7. PubMed ID: 11756609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
    Volonte D; Peoples AJ; Galbiati F
    Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters.
    Segal SS; Brett SE; Sessa WC
    Am J Physiol; 1999 Sep; 277(3):H1167-77. PubMed ID: 10484439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-3 and nitric oxide synthase I in healthy and diseased skeletal muscle.
    Gossrau R
    Acta Histochem; 1998 Feb; 100(1):99-112. PubMed ID: 9542584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.
    Sotgia F; Woodman SE; Bonuccelli G; Capozza F; Minetti C; Scherer PE; Lisanti MP
    Am J Physiol Cell Physiol; 2003 Nov; 285(5):C1150-60. PubMed ID: 12839838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain.
    Venema VJ; Ju H; Zou R; Venema RC
    J Biol Chem; 1997 Nov; 272(45):28187-90. PubMed ID: 9353265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased caveolin-3 levels in mdx mouse muscles.
    Vaghy PL; Fang J; Wu W; Vaghy LP
    FEBS Lett; 1998 Jul; 431(1):125-7. PubMed ID: 9684879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolae and caveolin-3 in muscular dystrophy.
    Galbiati F; Razani B; Lisanti MP
    Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
    Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
    J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin and NOS in the Development of Muscular Dystrophy.
    Nakashima M; Suga N; Yoshikawa S; Matsuda S
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.